ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Biomarkers"

  • Abstract Number: 1474 • ACR Convergence 2022

    Quinolinic Acid, a Kynurenine/Tryptophan Pathway Metabolite, Correlates with Abnormalities in Brain Structure and Function in SLE

    Erik Anderson, Chris Tang, An Vo, Cynthia Aranow, Bruce Volpe, Betty Diamond and Meggan Mackay, Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Stimulation of the kynurenine/tryptophan pathway by interferons alpha and gamma, both known contributors to SLE pathogenesis, leads to a potentially neurotoxic imbalance of pathway…
  • Abstract Number: 1642 • ACR Convergence 2022

    Mast Cells May Explain Sex Differences in Osteoarthritis Pain

    Bella Mehta1, Edward DiCarlo2, Fei Wang3, Miguel Otero4, Eun Kyung Song5, Peter Sculco2, Mark Figgie2, Susan Goodman2, William Robinson5 and Dana Orange6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Weil Cornell Medical College, New York, NY, 4Hospital for Special Surgery Research Institute, New York, NY, 5Stanford University School of Medicine, Palo Alto, CA, 6The Rockefeller University, New York, NY

    Background/Purpose: Women are at increased risk for knee osteoarthritis(OA) and report more severe pain than men at the time of total knee arthroplasty. It has…
  • Abstract Number: 1873 • ACR Convergence 2022

    Relationship Between Baseline Characteristics of Rheumatoid Arthritis and Types of Mortality: Study of Cohort Followed Prospectively

    Cristina Corrales1, Fabricio Benavides Villanueva1, Ivan Ferraz Amaro2, Nuria Vegas Revenga3, Virgi Portilla4, Ricardo Blanco5, Miguel Ángel González-Gay6 and Alfonso Corrales4, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 3Hospital Galdakao- Usansolo, Galdakao, Spain, 4Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 5Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 6Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of mortality mainly due to cardiovascular (CV) events, infections and malignancies. The relationship between the…
  • Abstract Number: 2085 • ACR Convergence 2022

    Effect of Osteoporosis on Major Adverse Cardiovascular Events (MACEs) and Mortality in Systemic Lupus Erythematosus: A Longitudinal Study

    Chi Chiu Mok1, Kar Li Chan2, Ling Yin Ho3 and Chi Hung To4, 1Tuen Mun Hospital, Hong Kong, China, 2Tuen Mun Hospital, Tsing Yi, Hong Kong, China, 3Tuen Mun Hospital, Hong Kong SAR, China, 4Pok Oi Hospital, Hong Kong, Hong Kong

    Background/Purpose: To study the effect of osteoporosis on major adverse cardiovascular events (MACEs) and mortality in a longitudinal cohort of patients with systemic lupus erythematosus…
  • Abstract Number: 2229 • ACR Convergence 2022

    Ultrasound Localization Microscopy as a New Tool for Takayasu’s Arteritis Activity Assessment, a Deep Insight Within Carotid Wall Inflammation

    Guillaume Goudot1, Anatole Jimenez2, Nassim Mohamedi3, jonas Sitruk3, Lina Khider1, Hélène Mortelette3, Clément Papadacci2, Fabien Hyafil4, Mickaël Tanter2, Emmanuel Messas1, Mathieu Pernot2 and Tristan Mirault1, 1Vascular medicine department, Georges Pompidou European hospital, APHP, Université Paris Cité, INSERM U970 PARCC, Paris, Ile-de-France, France, 2Physics for Medicine Paris, INSERM U1273, ESPCI Paris, CNRS FRE 2031, PSL Research University, Paris, France, 3Vascular medicine department, Georges Pompidou European hospital, APHP, Université Paris Cité, Paris, Ile-de-France, France, 4Nuclear medicine department, Georges Pompidou European hospital, APHP, Universite Paris Cite, INSERM U970 PARCC, Paris, Ile-de-France, France

    Background/Purpose: Use of sulphur hexafluoride microbubbles (MB) with ultrasound allow to assess arterial wall vascularization through signal enhancement. The use of ultrafast imaging with MB…
  • Abstract Number: 0023 • ACR Convergence 2022

    New Biomarkers in Hand Osteoarthritis: The Micro-RNA Signature

    Maxime Auroux1, Marjorie Millet2, Blandine Merle2, Elisabeth Fontanges1, Florence Duvert1, Evelyne Gineyts3, Jean-Charles Rousseau3, Olivier Borel2, Alexandre Mercier1, Eric LESPESSAILLES4 and Roland Chapurlat1, 1Hospices Civils de Lyon, LYON, France, 2INSERM U1033, LYON, France, 3INSERM 1033, Lyon, France, 4Regional hospital centre of Orleans, France, ORLEANS, Centre, France

    Background/Purpose: Hand osteoarthritis (HOA) is a highly prevalent disease, associated with important disability and socio-economic burden. Erosive HOA, almost exclusively found in women, induces more…
  • Abstract Number: 0300 • ACR Convergence 2022

    Exposure-Response Analyses of Upadacitinib Effects on Plasma Biomarkers in Rheumatoid Arthritis Patients

    Yuli Qian1, Fang Cai2, Thierry Sornasse3, Jie Shen1, Heidi Camp4 and Mohamed-Eslam Mohamed1, 1AbbVie, Inc., North Chicago, IL, 2AbbVie, Redwood City, CA, 3AbbVie, South San Francisco, CA, 4Abbvie, Winnetka, IL

    Background/Purpose: Upadacitinib (UPA) is an oral Janus kinase (JAK) inhibitor approved for the treatment of moderately-to-severely active rheumatoid arthritis (RA). Previous investigations demonstrated UPA modulates…
  • Abstract Number: 0536 • ACR Convergence 2022

    Change in Urinary Biomarkers at Three Months Predicts 1-year Treatment Response of Lupus Nephritis Better Than Proteinuria

    Andrea Fava1, Laurence S Magder2, Daniel W. Goldman3, Jill Buyon4, Betty Diamond5, Joel Guthridge6, William Apruzzese7, Derek Fine1, Jose Monroy-Trujillo1, Mohamed G. Atta1, Peter Izmirly4, H Michael Belmont8, Anne Davidson5, Maria Dall'Era9, Deepak Rao7, Arnon Arazi10, Nir Hacohen11, Soumya Raychaudhuri7, the Accelerating Medicines Partnership (AMP) RA/SLE12 and Michelle Petri3, 1Johns Hopkins University, Baltimore, MD, 2University of Maryland, Department of Epidemiology and Public Health, Baltimore, MD, 3Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD, 4NYU Grossman School of Medicine, New York, NY, 5Feinstein Institutes for Medical Research, Manhasset, NY, 6Oklahoma Medical Research Foundation, Oklahoma City, OK, 7Brigham and Women's Hospital, Boston, MA, 8NYU School of Medicine, New York, NY, 9University of California, San Francisco, San Francisco, 10Feinstein Institutes for Medical Research, Melrose, MA, 11Broad Institute, Cambridge, MA, 12Multiple Insitutions

    Background/Purpose: A decline of urine protein-to-creatinine ratio (UPCR) to < 0.5 is associated with better long-term preservation of kidney function in lupus nephritis (LN). UPCR…
  • Abstract Number: 0656 • ACR Convergence 2022

    Association Study Identified HLA-DQA1 as a Genetic Risk of Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension

    Junyan Qian1, Ying Chen2, Xinzhuang Yang3, Qian Wang4, JIULIANG ZHAO5, Xiaoyue Deng1, Shengjie Li3, Yongtai Liu6, Zhuang Tian6, Juan Shen2, Qijun Liao2, Yanhong Wang7, Xianbo Zuo8, Xuejun Zhang9, MENGTAO LI1, Yong Cui8, Xueqing Yu10 and Xiaofeng Zeng11, 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science & Technology, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, State Key Laboratory of Complex Severe and Rare Diseases, Ministry of Science & Technology, Beijing, China, 2BGI-Shenzhen, Shenzhen, China, 3Medical Research Center, State Key laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 4Peking Union Medical College Hospital, Beijing, China, 5Beijing Union Medical College Hospital, Beijing, China, 6Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China, 7Department of Epidemiology and Bio-statistics, Institute of Basic Medical Sciences, China Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 8Department of Dermatology, China-Japan Friendship Hospital, Beijing, China, 9Institute of Dermatology, Anhui Medical University, Hefei, China, 10Division of Nephrology, Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China, 11Department of Rheumatology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Beijing, China

    Background/Purpose: Pulmonary arterial hypertension (PAH) is a rare and severe complication of systemic lupus erythematosus (SLE). Human leucocyte antigen (HLA) gene variants in the major…
  • Abstract Number: 0933 • ACR Convergence 2022

    Exploratory Study of the Usefulness of TNFAIP3 Genetic Variants in Predicting Response to Methotrexate in Early Arthritis Patients

    Ana Triguero1, JUAN BALDIVIESO ACHA2, Emilia Roy Vallejo3, Patricia Quiroga-Colina4, Irene Maria Llorente Cubas2, Rosario Garcia-Vicuña5, amaya Puig kröger6 and Isidoro Gonzalez2, 1Hospital Universitario La Princesa, Madrid, Spain, 2Hospital Universitario de La Princesa, Madrid, Spain, 3Internal Medicine Department, Hospital Universitario La Princesa, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Madrid, Spain, 4Division of Rheumatology, Hospital Universitario de La Princesa, Madrid, Spain, 5Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain, 6Laboratory of Immunometabolism, Hospital General Universitario Gregorio Marañón, Madrid, Spain

    Background/Purpose: We recently described that methotrexate (MTX) could exert its immunomodulatory effect through the induction of A20 expression , a protein that negatively regulates NFkB…
  • Abstract Number: 1163 • ACR Convergence 2022

    Proteomic Investigation to Identify Urinary Biomarker for Ankylosing Spondylitis

    Ji-Hyun Lee1, Jeesoo Kim2, Sang-Hyon kim1, Jong‑Seo kim2 and Chang-Nam son1, 1Keimyung University, Dalseo-gu, Daegu, Republic of Korea, 2seoul national university, Seoul, Republic of Korea

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease that affects the spine and peripheral joints, and the exact etiology is still unknown. Diagnosis…
  • Abstract Number: 1478 • ACR Convergence 2022

    Urine ALCAM Is a Strong Predictor of Lupus Nephritis

    Dalena Chu1, Noa Schwartz2, Jeanette Ampudia1, Joel Guthridge3, Judith James3, Jill Buyon4, Stephen Connelly1, Maple Fung1, Cherie Ng1, AMP SLE/RA consortium5, Michelle Petri6, Chandra Mohan7 and Chaim Putterman8, 1Equillium, Inc., La Jolla, CA, 2Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, 3Oklahoma Medical Research Foundation, Oklahoma City, OK, 4NYU Grossman School of Medicine, New York, NY, 5Accelerating Medicines Partnership, Los Angeles, CA, 6Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, MD, 7University of Houston, Houston, TX, 8Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: T cells play a critical role in the pathogenicity of SLE and lupus nephritis (LN). Hence, identifying T cell co-stimulatory pathways and mediators that…
  • Abstract Number: 1650 • ACR Convergence 2022

    Systemic Immune Inflammation Index Predict All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis

    Jose felix Restrepo Suarez1, Inmaculada Del Rincon1, Carlos Lorenzo2 and Agustin Escalante3, 1University of Texas Health Science center at San Antonio, San Antonio, TX, 2University of Texas Health Sciences Center San Antonio, San antonio, TX, 3University of Texas Health Science Center at San Antonio, San Antonio, TX

    Background/Purpose: The systemic immune inflammation index (SII) is an inflammation-based biomarker that is an influential prognostic factor in diseases with an inflammation-related etiology. This index…
  • Abstract Number: 1874 • ACR Convergence 2022

    Autoantibodies Are Common in Patients with Idiopathic Interstitial Lung Disease Suggesting a High Prevalence of Undiagnosed Autoimmune Connective Tissue Disease

    Sarah Tansley1, Caroline Cotton2, Fionnuala McMorrow1, Hui Lu1, Aravinthan Loganathan1, Zoe Betteridge1, Robert New3, Lisa Spencer4, Neil McHugh1 and Robert Cooper4, 1University of Bath, Bath, United Kingdom, 2Liverpool University Hospital, Liverpool, United Kingdom, 3NCA, Manchester, 4University of Liverpool, Liverpool

    Background/Purpose: In some patients, interstitial lung disease (ILD) may be the dominant or even sole overt manifestation of an otherwise unrecognised autoimmune connective tissue disease…
  • Abstract Number: 2096 • ACR Convergence 2022

    Role of Cell-Bound Complement Fragments as Biomarkers to Determine Disease Activity in Patients with Systemic Lupus Erythematosus

    Marcela Muñoz Urbano1, Diana C. Quintero-González1, Mauricio Rojas2, Joaquín Rodelo1, Alba Luz León Álvarez1, Luis Gonzalez1 and Gloria Vásquez3, 1Universidad de Antioquia, Medellín, Colombia, 2Grupo de Inmunología Celular e Inmunogenética, GICIG, and Unidad de citometría de flujo, Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia, 3Grupo de Inmunología Celular e Inmunogenética, GICIG and Grupo de Reumatología, Universidad de Antioquía, Medellín, Colombia

    Background/Purpose: The prompt identification of patients with systemic lupus erythematosus (SLE) at risk of or in flare strongly influences the prognosis of the disease. Cell-bound…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 96
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology